# JW Pharmaceutical Corporation - Sihwa Plant – FDA Inspection, Mar 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/jw-pharmaceutical-corporation-sihwa-plant/46400ce4-fe9a-44d1-84ad-d2c3ae93f166
Source feed: FDA_Inspections

> FDA inspection 1201702 of JW Pharmaceutical Corporation - Sihwa Plant, March 17, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201702
- Company Name: JW Pharmaceutical Corporation - Sihwa Plant
- Inspection Date: 2023-03-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1072631 - 2018-10-26

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/saied-a-asbagh/215bfa90-995f-4310-baf3-cd9d37639b7b)

Company: https://www.keypedia.com/companies/jw-pharmaceutical-corporation-sihwa-plant/ec30f14a-9d0d-44a3-a946-676072d8ebdf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c